印度尼西亞緝毒形勢(shì)_第1頁(yè)
印度尼西亞緝毒形勢(shì)_第2頁(yè)
印度尼西亞緝毒形勢(shì)_第3頁(yè)
印度尼西亞緝毒形勢(shì)_第4頁(yè)
印度尼西亞緝毒形勢(shì)_第5頁(yè)
已閱讀5頁(yè),還剩27頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

COMBATINGCOUNTERFEITDRUGSININDONESIAFirstASEAN-ChinaConferenceonCombatingCounterfeitMedicalProductsJakarta,13-15November2007NationalAgencyofDrugandFoodControlIndonesiaBACKGROUNDlocatedbetweentwocontinentsandtwooceans,whichiseasilyaccessiblebyland,sea,orair.someproblemsarestillbeingfaced,blemsmayarisefromborderlineareas,whicharesusceptibletosmuggled,counterfeitmedicines.RegardingcounterfeitmedicinestheymaybeIllegallyimportedorLocallymanufacturedbyillegalmanufacturerINDONESIADistributedtoillegalmarketFREETRADEZONEFreeTradeZoneBATAM,includingBatamIsland,TontonIsland,SetotokIsland,NipahIsland,RempangIsland,GalangIslandandGalangBaruIsland.FreeTradeZoneBINTAN,includingGalangBatangIndustrialEstate,MaritimIndustrialEstate,andLobanIsland,SenggarangIndustrialEstateandDompakBaratIndustrialEstateFreeTradeZoneKARIMUN,includingnumberofKarimunIsland,KarimunAnakIslandFreeTradeZoneSABANG.NUMBEROFINTERNATIONALPORTSEAPORT:141AIRPORT:10

LEGISLATIVE

INFRASTRUCTUREBORDERPOSTEffortshavebeentakenbyestablishingBorderPostsinsomeareas,i.e:SKOU(PapuaNewGuinea)MOTAAIN,NAPAN&METAMAUK(TimorLeste)MARORE&MIANGAS(Philipine)ENTIKONG&JAGOIBABANG(EastMalaysiaLand)NUNUKAN(EastMalaysiaOcean)SUNGAIGUNTUNG(WestMalaysiaOcean)SAMBUBELAKANG,PADANG&TAREMPA(WestMalaysiaOcean)Objective:

TocontrolimportedgoodsTominimizeillegal&counterfeitdrugsenteringthecountryDefinitionCounterfeitDrugs(CD’s)definitioninIndonesiabasedonIndonesianMoHDecreeNo.949/2000:Amedicinalproductwhichismanufacturedbyillegalmanufacturerordeliberatelymislabeledwithrespecttoidentityofregisteredproduct.BasicLawandRegulationrelateddrugcounterfeitingLawNo.1/1946onCriminalActLawNo.23/1992onHealthLawNo.8/1999onConsumerProtectionLawNo.14/2001onPatentLawNo.15/2001onMarkNUMBEROFCASESCOUNTERFEITDRUGSFINDINGFREQUENCIES

PERIOD2001-2007(October)frequency*Thedataismadefromfindingfrequencies>3timesCounterfeitdrugsNUMBEROFCASESSUSPECTEDCONFIRMEDIMPORTED/DOSMETICVITALMEDICAL20072*2ImportandDomesticYes200611DomesticNo200533DomesticYes(injectable)*aresultofjointoperationwherebyanillegalwarehousewasfoundfilledwiththousandofboxesof26itemsofcounterfeitmedicines,withanestimatedvalueofupto25billionrupiahsHOWWHERETHESECASESDETECTED%ornumberofcasesPatientscomplaintsNODATAAVAILABLEHealthprofessionalsreportsNODATAAVAILABLEEnforcement/investigationworkNODATAAVAILABLERoutinechecksNODATAAVAILABLEReportedbyaffectedmanufacturer28,6%(2005),20%(2006),4,16%(2007)NUMBEROFPROSECUTIONS/CONVICTIONS/PENDINGMANUFACTURERWHOLESALER/IMPORTERRETAILERINFORMALSECTOR20071(inprocess)1(inprocess)2006--1(inprocess)-2005--3(2Sentencepenalty,1WantedList)-NADFCDATANATIONALCOORDINATIONMechanismofnationalcoordination

CombatingCounterfeitDrugsrequiresjointeffortDrug/NationalRegulatoryAuthorityHealthcare&medicineprovidersCivilsocietiesPatientInterestGroupsPatients/consumersDrugmanufacturersimporters&wholesalersmedicinesMinistries,police,customs,ProsecutorsGovernmentmedicinesBENEFITS&LIMITATIONSOFCOORDINATIONBENEFITSTechnicalsupportsuchaslaboratorytest,expertwitnessstatementwillbeprovidedbyNADFCifneededIffacingdifficulties,forceeffortwillbeprovidedbythePoliceProvidedinformationofimport-registeredproductsforthecustomSeveralLawsandregulationasbasiclegalprocesstocombatCounterfeitDrugsareavailableLIMITATIONSLackofthereferencestandardavailableinNQCLLackofcoordinationamonglawenforcementagenciesatalllevel(National-provincial-district)On-linesystemisnotinplaceWeaknessofImplementationofsomeLaws,suchasneedappealfromthemanufacturingauthorizationholderofauthenticdrugsSTRATEGICACTIONONCOMBATINGCOUNTERFEITDRUGS(CDs)inINDONESIAILEGALMANUFACTURERILLEGALMARKETILEGALDISTRIBUTORCONSUMERFACTS:CDsarefound,mostlyinillegalmarketDifficulttodifferenciatewiththegenuineoneLackofpublicawareness(consumersbuydrugsintheillegalmarket)STRATEGIES:BreakinguptheIllegalchainSustainablelawenforcementwithdeterrentpenaltiesRevealmodusoperandi,identifytheintellectualactorsandtheirnetwork

NationalProgram;Comprehensiveinvestigationandmopping-upwhatisalreadyincirculationNationalJointOperationandjointinvestigatinwithpolice(inilegalmarket)StrenghteningtheinfrastructureImprovementcollaborationandcoordinationwithotherlawenforcementagenciesIncreasingcomprehensivedrugdistributioncontrolIncreasingpublicawarenessandlawenforcementagenciesREGIONALLEVELGAPSIMPLICATIONSSTRATEGYInter-sectoralcoordinationisnotbasedonwrittenprocedurewhichareclearlydefinedroles,adequateresourcesandeffectiveadministrativeandoperationaltools.Lackofawarenessabouttheseverityoftheproblemamongstakeholder.NospecificlawonCounterfeitDrugs.LimitationofreferencestandardonNQCLNocomprehensiveprogramoncombatingcounterfeitdrugsNodeterrentsanctionsNodeterrentsanctionsThetimelineoflabresultisnotonscheduleDevelopnationaltskforceoninter-sectoralcoordinationbaseonwrittenprocedures,clearlydefinedroles,adequateresources,andeffectiveadministrativeandoperationaltools.Increasingawarenessontheharmful/impactofcounterfeitdrugsthroughseminarforthespecifictargetgroupssuchasPharmaceuticalManufacturer,Healthprofessionals,patients,trainingforLawenforcementAgencies,andDRAAssistnationalauthoritiestodevelopriskcommunicationandadvocacymaterialsDevelopdraftoncounterfeitdrugsLawNeedcollaborationtogetreferenceatandardassistbyWHOREGIONALLEVELGAPSIMPLICATIONSSTRATEGYLackofInformationExchangeamongcountries,nodesignatedpersoninchargeatDRADifferentdefinitionofCounterfeitDrugsamongCountriesLackofnetworkingonCounterfeitdrugsproblemamongASEANDRAs

difficultiesoncontactingthepersoninchargeDifferentfollowupactiondifficultytoknowthegenuityofthesuspecteddrugDifficultytotracethesuspectiftheyescapetoothercountriesPromotenetworkingandcollaborationamongASEANDRAoncounterfeitdrugsDevelopTORwhichareincludediscussionamongASEANcountrieson:thedefinitionofcounterfeitdrugs.Surveyexistingnationalandinternationallegislation&requirementsAssessexistingnationalbestpracticesanddevelopmodelbestpracticesPromotesecureexchangeofinformationandalertsamongASEANDRADevelopmentofcommondefinitionofcounterfeitdrugwithinASEANCountriesDevelopmentASEANSchemeontacklingofcounterfeitdrugsDevelopmentaRegionalStrategyandSystematicProgramProposedProjectagainstCounterfeitDrugsOUTPUTExchangeofinformationbydesignatedunitofDRADevelopdatabaseofcounterfeit

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論